HomeOpen Access NewsCancer Research

Cancer Research

The interplay between cancer and antimicrobial resistance

Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).

A new generation of testing for cancer: tools for navigating data in clinical decision making

Utilising early cancer detection: Are we getting the most out of first order tests for symptomatic cancer patients?

Beating lung cancer with the AI edge

Prashant Warier, CEO and Founder, Qure.ai, explains beating lung cancer with the AI edge.

Digital cytology and the future of cervical cancer screening

Cervical cancer is a disease affecting thousands of women in the UK with around 3,200 new cases diagnosed every year, can developments in cervical screening and digital cytology help?

Reducing medical costs of patients with thyroid cancer by centralising medical functions

Professor Hiroki Konno at Nihon University explores proposals for reducing medical costs for patients with thyroid cancer in Japan.

Genomic instability and nuclear architecture in cancer

Sabine Mai and Aline Rangel-Pozzo, at the CancerCare Manitoba Research Institute and The University of Manitoba, Winnipeg, Canada, discuss genomic instability in relation to 3D spatial organization of telomeres.

Banning indoor tanning beds would prevent skin cancer

Banning commercially available indoor tanning beds would prevent skin cancer and reduce deaths from the most serious form of skin cancer known as melanoma.

WSK Medical: Changing healthcare by leveraging innovative AI solutions

Using AI solutions to assist clinicians and doctors in the quest for early cancer detection through software.

Former cancer patients not more likely to die from COVID

A study finds that former cancer patients are not more likely to die from COVID than non-cancer patients, if they aren't having active treatment.

Individualised Multimodal Immunotherapy beyond personalised medicine for brain cancer

Stefaan Van Gool, MD, PhD brings to light the important role of Individualised Multimodal Immunotherapy in improving the survival of brain cancer.

“Inadequate” UK cancer services risk late diagnosis for patients

According to a report, more than 340,000 cancer patients could face late diagnosis - due to NHS staff shortages.

Cytomegalovirus & glioblastoma: Solving the riddle

Sean Lawler, Associate Professor at Brown University, explains solving the riddle when it comes to the cytomegalovirus virus and the lethal brain tumour, glioblastoma.

Visualising genomic instability in cancer

Sabine Mai and Aline Rangel-Pozzo from CancerCare Manitoba Research Institute, The University of Manitoba, explore how 3D imaging and quantitative analysis provide key insights into genomic instability.

Cholangiocarcinoma research and asbestos exposure

Professor Giovanni Brandi and Dr Simona Tavolari, explore the link between asbestos exposure and cholangiocarcinoma malignancies

Therapeutic feline and canine cancer vaccine

Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.

A new wave of molecular cancer therapeutics

Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.

Medical cannabis & the future of cancer treatments   

Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders